UTILITY Therapeutics is a brand dedicated to addressing the urgent treatment needs for multi-drug resistant infections. With a focus on combating the growing threat of antibiotic resistance, UTILITY Therapeutics is committed to developing innovative antibiotics for the US market. Antibiotic resistance is a significant global health concern, with almost 3 million antibiotic-resistant infections occurring annually in the United States alone.

In response to this critical issue, UTILITY Therapeutics is developing new antibiotic options, specifically targeting urinary tract infections (UTIs). Led by a team of industry leaders experienced in the launch and commercialization of anti-infectives, UTILITY Therapeutics is at the forefront of the fight against antibiotic resistance. They have achieved key milestones in the preparation of pivmecillinam for NDA-filing, ensuring the availability of effective and essential treatments.

Join UTILITY Therapeutics in their mission to provide new solutions to combat antibiotic resistance and improve treatment outcomes